The Latest Breaking News from Eli Lilly

Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns

After tanking on Novo's "Wegovy Pill" release, Eli Lilly shares reversed course. See why investors may like its acquisition of Ventyx Biosciences.

MarketBeat · Jan 13

Popular weight-loss drugs shouldn't carry suicide warnings, FDA says

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their blockbuster weight-loss drugs

The Independent UK · Jan 13

What to Expect From Eli Lilly’s Q4 2025 Earnings Report

Eli Lilly is gearing up to announce its fiscal 2025 fourth-quarter earnings in the near term, and analysts project its earnings to rise in double-digits.

Barchart · Jan 13

Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war

First and only GLP-1 pill on the market costs significantly less than injectable versions

The Guardian - UK · Jan 5

Novo Nordisk's Future Vision on 'Weight Loss' Wins Scientists, Tests Wall Street's Patience

Novo Nordisk's long-term strategy for weight-loss treatments has earned praise from scientists, even as investors grow cautious about timelines, competition and near-term returns.

International Business Times UK · Dec 30, 2025

Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026

Eli Lilly has been a huge winner in the last few months of 2025. New clinical data support its outlook in 2026, with large potential catalysts on the horizon.

MarketBeat · Dec 26, 2025

As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?

As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now?

Barchart · Dec 25, 2025

Asian shares are mixed after US stocks drift to more records

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas

The Independent UK · Dec 25, 2025

India’s doctors sound alarm over boom in availability of weight loss jabs

Country is facing epidemic of diabetes and obesity, but experts say widespread and unregulated use of weight loss drugs could put patients at risk

The Guardian - UK · Dec 20, 2025

More drug companies sign on to Trump’s health exchange that promises to lower prescription prices

Administration officials say the ‘Trump Rx’ website should be up and running next month

The Independent UK · Dec 19, 2025